Delivery Order SPE2DB25D7068-SPE2DB25FTXGF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Logistics Agency awarded a $1,199.28 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This is a firm fixed-price, non-set-aside contract with a completion date of September 11, 2025, and performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's significant role as a critical pharmaceutical...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 500 units, with a contract ceiling value of $2,077.68. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, valued at $2,151.96. This is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,369.59 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (500 count) under a firm fixed price contract type. The award, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive set-aside delivery order fulfilled from the vendor's existing contract vehicle. Performance will be completed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,402.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The order is scheduled for ultimate completion by June 20, 2025, and will be performed at AmerisourceBergen's corporate office...
- On July 21, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,268.75 to AmerisourceBergen Drug Corp for 1,000 tablets of Doxycycline Hyclate 100 mg. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 22, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a ceiling value of $3,597.84. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in a quantity of 1,000 units, valued at $1,565.14. This contract utilizes firm fixed pricing and carries an ultimate completion date of July 11, 2025. The award represents a non-set-aside, competitively awarded delivery order with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,736.07 to AmerisourceBergen Drug Corp for the procurement of Doxycycline Hyclate 100 mg tablets (1,000 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This delivery order was issued under a firm fixed price structure with no set-aside designation, awarded through open competition. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. As...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTXGFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (1,000 count) on July 15, 2025, with a ceiling value of $1,299.23 and ultimate completion by July 16, 2025. This firm fixed-price delivery order represents a small-value pharmaceutical transaction within the federal medical supply chain. The contract is not designated as a set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a broad portfolio of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded contracts demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains, including antibiotics, specialty medications, and vaccines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/15/25 |